Position history for BNP PARIBAS FINANCIAL MARKETS's holdings in APELLIS PHARMACEUTICALS INC
BNP PARIBAS FINANCIAL MARKETS holds 584,192 shares of APLS (APELLIS PHARMACEUTICALS INC), worth $23.5M as of 2026-Q1. The position was increased (+4.8% shares). APLS represents 0.0% of BNP PARIBAS FINANCIAL MARKETS's portfolio.
Current Value
$23.5M
Current Shares
584,192
Total Value Change
+$19.5M
Total Shares Change
+479,774
Other major holders of APLS: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC, BANQUE PICTET & CIE SA
Increased |
| 584,192 |
+4.8% |
| $23.5M |
| 0.0% |
| $20.16 |
30 |
| 2025-Q4 | Decreased | 557,591 | -42.7% | $14M | 0.0% | $25.24 | 0 |
| 2025-Q3 | Decreased | 972,474 | -25.1% | $22M | 0.0% | $22.65 | 0 |
| 2025-Q2 | Increased | 1.3M | +16.9% | $22.5M | 0.0% | $17.43 | 33 |
| 2025-Q1 | Increased | 1.1M | +30.6% | $24.3M | 0.0% | $24.27 | 36 |
| 2024-Q4 | Increased | 850,823 | +432.8% | $27.1M | 0.0% | $31.90 | 46 |
| 2024-Q3 | Increased | 159,700 | +52.9% | $4.6M | 0.0% | $29.47 | 38 |
| 2024-Q2 | Increased | 104,418 | +102.3% | $4M | 0.0% | $38.36 | 43 |